跳至正文
佰默生物 项目咨询
首页/SIMOA/Assay Kits

SIMOA / ASSAY

Alpha-Synuclein (Total)

Alpha-synuclein is a presynaptic neuronal protein involved in vesicle trafficking and neurotransmitter release. In Parkinson’s disease (PD) and related synucleinopathies, misfolded and aggregated forms of alpha-synuclein accumulate in Lewy bodies, contributing to neurodegeneration and disease progre…

Alpha-Synuclein (Total) 原有产品资料图
原有产品资料图 · 点击放大查看
查看完整产品简介

询价 (Tel. 15750729215)

Alpha-Synuclein (Total)

A Fluid Biomarker for Parkinson’s Disease and Synucleinopathies

Alpha-synuclein is a presynaptic neuronal protein involved in vesicle trafficking and neurotransmitter release. In Parkinson’s disease (PD) and related synucleinopathies, misfolded and aggregated forms of alpha-synuclein accumulate in Lewy bodies, contributing to neurodegeneration and disease progression. Measuring total alpha-synuclein in plasma, serum, or CSF provides important insight into central nervous system pathology and may enable early detection, staging, and treatment response monitoring.

产品说明

A Fluid Biomarker for Parkinson’s Disease and Synucleinopathies

Alpha-synuclein is a presynaptic neuronal protein involved in vesicle trafficking and neurotransmitter release. In Parkinson’s disease (PD) and related synucleinopathies, misfolded and aggregated forms of alpha-synuclein accumulate in Lewy bodies, contributing to neurodegeneration and disease progression. Measuring total alpha-synuclein in plasma, serum, or CSF provides important insight into central nervous system pathology and may enable early detection, staging, and treatment response monitoring.

Due to its low abundance in blood and CSF and interference from peripheral alpha-synuclein, ultra-sensitive methods are required to measure total alpha-synuclein accurately. The Simoa® Alpha-Synuclein (Total) Advantage PLUS Assay (105737) leverages digital immunoassay technology to enable femtogram-level detection, supporting research into PD and other neurodegenerative conditions.

Key Benefits of the Simoa Alpha-Synuclein Assay

  • Femtogram-Level Detection in Biofluids: Accurately measures low-abundance alpha-synuclein in serum, EDTA plasma, and CSF, critical for detecting early disease signals and differentiating disease stages.
  • Automated High-Throughput Workflow on HD-X: Enables reproducible results across large cohorts with minimal operator variability and full automation.

Biological and Clinical Relevance

  • Neurodegenerative Disease Research: Alpha-synuclein is central to Parkinson’s disease, Dementia with Lewy Bodies (DLB), and Multiple System Atrophy (MSA). This assay supports biomarker studies focused on diagnosis, progression, and therapeutic impact.
  • Clinical Trial Utility: Facilitates longitudinal tracking of synuclein-targeting interventions, providing a quantifiable readout of treatment response.
  • Complementary to Tau and Amyloid Biomarkers: Enables multi-pathway biomarker panels for disease differentiation and staging in atypical parkinsonian syndromes and mixed pathology dementias.

Powering Synuclein Research with Simoa®

Quanterix’s Simoa® platform offers the precision and scalability needed to quantify biomarkers like alpha-synuclein in complex matrices with exceptional accuracy. This assay supports:

  • Parkinson’s disease biomarker research
  • Synucleinopathy staging and stratification
  • Monitoring drug response in clinical trials
  • Fluid-based alternatives to invasive diagnostics

Applications and Intended Use

The Simoa Alpha-Synuclein (Total) Advantage PLUS Assay is a digital immunoassay intended for the quantification of total alpha-synuclein in human serum, EDTA plasma, and CSF samples, enabling research in Parkinson’s disease and other synucleinopathies. This assay is for research use only and not for diagnostic applications.

Assay Specifications

  • Compatible Instruments: HD-X
  • Lower Limit of Detection (LOD): 2.4736 pg/mL
  • Analytical Lower Limit of Quantification (LLOQ): 8.7040 pg/mL
  • Sample Types: Serum, EDTA plasma, CSF
  • Sample Volume Required:
    • Serum/Plasma: 3.125 µL/test
    • CSF: 12.5 µL/test

Kit Contents

The Alpha-Synuclein (Total) Advantage PLUS Assay Kit includes all reagents and controls necessary to perform 96 tests, ensuring consistency and reliability in every run.

资料下载

保留原有原厂资料入口。不同仪器与版本的参数,请逐一核对对应文件。

您想从哪一步开始?

BIOMO / 站内搜索

你想找到什么?

从产品、科研服务到技术资料。

常用检索

单细胞VisiumDDA / DIASIMOAmIHCOlink

评估科研项目

留下研究目标和联系方式,便于进一步沟通。

不确定的项目可以留空,我们一起确认。

提交的信息将用于回复本次咨询,由佰默团队接收处理。

也可联系 panxu@biomobio.com